Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcyclin binding protein pseudogene 2 (CACYBPP2) is annotated as a pseudogene in the human genome (NCBI Gene ID: 644877)[2]. Pseudogenes are genetic elements similar to protein-coding genes but are considered non-functional and do not encode active proteins. CACYBPP2 is distinct from the functional calcyclin binding protein gene (CACYBP), which is involved in calcium-dependent ubiquitination and proteasomal degradation of proteins. As a pseudogene, CACYBPP2 is not a molecular target, does not have characterized biological functions, is not associated with disease, and is not a subject for therapeutic intervention[2]. No substantial or structured information is available for CACYBPP2 in drug or disease databases, and it should not be confused with the active CACYBP gene or protein[1][3][7]. Summary: CACYBPP2 is a pseudogene, not a functional protein or therapeutic target, and should not be used as a drug discovery target. If your query was intended for the functional calcyclin binding protein (CACYBP), please specify, as more information is available for CACYBP.
None applicable (not a protein, not druggable)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcyclin binding protein pseudogene 2 (CACYBPP2).